A downtrend has been apparent in Relay Therapeutics, Inc. (RLAY) lately with too much selling pressure. The stock has declined 31.1% over the past four weeks. However, given the fact that it is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback